Walgreens has unveiled a new value-oriented store brand chainwide. Called Nice!, the brand includes more than 400 grocery and household products at prices up to 30% below those of national brands. The 7,750-store chain plans to have most Nice! products on shelves by early 2012.
The generic drug industry and the Food and Drug Administration have reached tentative agreement to establish a user fee program in which companies would pay as much as $299 million initially to hasten drug approvals and increase the frequency of FDA inspections of foreign drug plants.
Retail veteran Ken Keelor has been named chief merchandising officer at Katz Group. In that role, Keelor will oversee all merchandising and marketing functions for the Rexall family of pharmacies.
Before there is a dazzling store, there has to be a magnificent space. Duane Reade had such a space at 40 Wall Street, and it shows in the chain’s bold new drug store there.
Pharmacy groups have joined a pending case before the U.S. Supreme Court to determine if cuts to the reimbursement rates paid under Medicaid violate federal law.
Charlie Bowlus is being remembered by chain drug and manufacturing executives as much for his disarming warmth and sincerity as for breaking new ground in retailer-supplier relations. Bowlus, founder and chief executive officer of ECRM, died this month of complications from emergency surgery.
As stocks gyrated and the economy sputtered, the leaders of CVS Caremark Corp. and Walmart called for Congress to restructure the corporate tax code.
Through national programs, local public-private initiatives and individual efforts of chain drug stores, retail pharmacists are gaining increased recognition as providers of influenza vaccinations.
Public relations and communications veteran Susan Henderson has joined Rite Aid Corp. as senior vice president and chief communications officer. She replaces Karen Rugen, who retired last month.
Dana Green, executive vice president, general counsel and corporate secretary at Walgreen Co., is retiring after 37 years with the company and is being replaced by Thomas Sabatino. Walgreens said Monday that Sabatino, who will have the same title, is slated to take over the post effective Sept. 12.
As a share repurchase program begun last year winds down, CVS Caremark Corp. is planning another one twice as large. The company said Wednesday that its board has authorized up to $4 billion in buybacks of its common stock.
As the leaders of community pharmacy gather in Boston for the National Association of Chain Drug Stores Pharmacy and Technology Conference, the profession continues to confront a number of unresolved issues that could have a direct bearing on its ability to provide accessible, affordable patient car
With Hurricane Irene rolling along the East Coast, chain drug retailers are making sure that customers can rely on their neighborhood drug store for their vital medications and key supplies so they can be prepared.
Unilever plans to sell rights to the Alberto VO5 and Rave hair care brands to private equity firm Brynwood Partners VI L.P. The consumer products giant said Wednesday that the divestiture is required by the U.S. Department of Justice in the wake of its $3.7 billion acquisition of the Alberto
Under a partnership agreement, pharmacy automation supplier Innovation plans to distribute RxSafe’s line of automated, high-density robotic storage and retrieval systems.
